No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
HIMS241213P43500
- 0.00
- 0.000.00%
15min DelayClose Dec 12 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest43.50Strike Price0.00Turnover0.00%IV-44.57%PremiumDec 13, 2024Expiry Date13.41Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.26Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Hims & Hers Health Insider Sold Shares Worth $2,653,129, According to a Recent SEC Filing
Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups'
Unusual Options Activity: CRDO, HIMS and Others Attract Market Bets, CRDO V/OI Ratio Reaches 105.2
EST Dec 12th Afternoon Delivery - In the last two hours of trading, 7 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Challenging Outlook for Hims & Hers Health Amid DTC Model Disruption and Profit Margin Concerns
'Eli Lilly to Sell Zepbound Through Telehealth Company Ro' - Barron's